NEURODEGENERATIVE DISEASE: Two–for–one on potential therapies

    loading  Checking for direct PDF access through Ovid

Abstract

Molecules that inhibit the synthesis of the ataxin 2 protein can ameliorate the effects of two neurodegenerative diseases in mouse models, raising hopes for the success of this approach in clinical trials. See Letters p.362 & p.367

Related Topics

    loading  Loading Related Articles